China Universal Asset Management Company’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
DC
HP
PFSRSONJ
YIH
FISPB
WMA
ETC
China Universal Asset Management Company's IONS Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Ionis Pharmaceuticals (IONS) stake by 1.3% in Q2 2026, selling an estimated $76.2K and leaving 76,302 shares worth $6.05M. The position accounts for 0.36% of the portfolio, ranked #56.
China Universal Asset Management Company first reported a position in IONS in Q3 2022 and has held it in 16 quarters since. 84 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- China Universal Asset Management Company held 76,302 shares of Ionis Pharmaceuticals worth $6.05M as of Q2 2026.
- China Universal Asset Management Company sold 1,013 Ionis Pharmaceuticals shares in Q2 2026, an estimated $76.2K.
- Ionis Pharmaceuticals made up 0.36% of China Universal Asset Management Company's portfolio in Q2 2026, its #56 holding.
- China Universal Asset Management Company first reported a position in Ionis Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
- 84 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.